Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency

Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency

US Patent 12291507 · Granted May 6, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2022